ONE-YEAR RESULTS OF TENOFOVIR AND EMTRICITABINE WITHOUT IMMUNOGLOBULIN TO PREVENT HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION

被引：3
|
作者：
Wesdorp, D. J. [1 ]
Knoester, M. [1 ]
Coenraad, M. J. [1 ]
Braat, A. E. [1 ]
Claas, E. C. [1 ]
van Hoek, B. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)60243-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
230
引用
收藏
页码：S96 / S97
页数：2
相关论文
共 50 条
  • [1] Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation
    Stravitz, R. Todd
    Shiffman, Mitchell L.
    Kimmel, Melissa
    Puri, Puneet
    Luketic, Velimir A.
    Sterling, Richard K.
    Sanyal, Arun J.
    Cotterell, Adrian H.
    Posner, Marc P.
    Fisher, Robert A.
    [J]. LIVER INTERNATIONAL, 2012, 32 (07) : 1138 - 1145
  • [2] Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation
    Teperman, Lewis W.
    Poordad, Fred
    Bzowej, Natalie
    Martin, Paul
    Pungpapong, Surakit
    Schiano, Thomas
    Flaherty, John
    Dinh, Phillip
    Rossi, Stephen
    Subramanian, G. Mani
    Spivey, James
    [J]. LIVER TRANSPLANTATION, 2013, 19 (06) : 594 - 601
  • [3] Tenofovir-Emtricitabine Therapy for the Prevention of Hepatitis B Recurrence in Four Patients After Liver Transplantation
    McGonigal, Katrina H.
    Bajjoka, Iman E.
    Abouljoud, Marwan S.
    [J]. PHARMACOTHERAPY, 2013, 33 (09): : E170 - E176
  • [4] Efficacy of lamivudine monotherapy following one-year course of hepatitis B immunoglobulin in preventing hepatitis B virus recurrence after living donor liver transplantation
    Kawagishi, Naoki
    Takeda, Ikuo
    Miyagi, Shigehito
    Satoh, Kazushige
    Akamatsu, Yorihiro
    Sekiguchi, Satoshi
    Satomi, Susumu
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 258 - 258
  • [5] Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin
    Engler, S
    Sauer, P
    Klar, E
    Stremmel, W
    Kallinowski, B
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2285 - 2287
  • [6] Necessity of Hepatitis B Immunoglobulin in Prophylaxis of Hepatitis B Virus Recurrence Recurrence After Liver Transplantation
    Wu, Linwei
    Wang, Peijie
    Tai, Qiang
    Wu, Chenglin
    Wang, Dongping
    He, Xiaoshun
    [J]. TRANSPLANTATION, 2015, 99 : 103 - 103
  • [7] EFFICACY OF NUCLEOSIDE ANALOGUE MONOTHERAPY FOLLOWING ONE-YEAR COURSE OF HEPATITIS B IMMUNOGLOBULIN PLUS NUCLEOSIDE ANALOGUE IN PREVENTING HEPATITIS B VIRUS RECURRENCE AFTER LIVING DONOR LIVER TRANSPLANTATION
    Kawagishi, Naoki
    Nakamura, Atsushi
    Iwane, Takeru
    Takeda, Ikuo
    Miyagi, Shigehito
    Satoh, Kazushige
    Akamatsu, Yorihiro
    Sekiguchi, Satoru
    Satomi, Susumu
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 200 - 200
  • [8] Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation
    Congly, Stephen E.
    Burak, Kelly W.
    Coffin, Carla S.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 429 - 436
  • [9] Recurrence of B Viral Hepatitis Despite Hepatitis B Immunoglobulin Prophylaxis after Liver Transplantation
    Hu, Xu-Guang
    Jung, Jae-Sung
    Kim, Bong-Wan
    Kim, Kyung-Min
    Wang, Hee-Jung
    [J]. TRANSPLANTATION, 2016, 100 : S254 - S254
  • [10] EMTRICITABINE TENOFOVIR DF COMBINATION plus /- HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTS
    Teperman, L.
    Spivey, J.
    Poordad, F.
    Schiano, T.
    Bzowej, N.
    Pungpapong, S.
    Martin, P.
    Coombs, D.
    Hirsch, K. R.
    Anderson, J.
    Rousseau, F.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S12 - S13
12345